Description
AZD-8330 is an inhibitor of MEK1/2 that exhibits anticancer chemotherapeutic activity. AZD-8330 is currently in clinical trials for the treatment of advanced stage cancers.
Product Unit Size | Cost | Quantity | Stock |
---|
AZD-8330 is an inhibitor of MEK1/2 that exhibits anticancer chemotherapeutic activity. AZD-8330 is currently in clinical trials for the treatment of advanced stage cancers.
Cas No. | 869357-68-6 |
---|---|
Purity | ≥98% |
Formula | C16H17FlN3O4 |
Formula Wt. | 461.23 |
IUPAC Name | 2-(2-fluoro-4-iodoanilino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxopyridine-3-carboxamide |
Synonym | ARRY-704, ARRY-424704 |
Solubility | DMSO 92 mg/mL (199.46 mM) Ethanol 92 mg/mL (199.46 mM) Water Insoluble |
Appearance | White Powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Cohen RB, Aamdal S, Nyakas M, et al. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9. PMID: 23433846.
Akinleye A, Furqan M, Mukhi N, et al. MEK and the inhibitors: from bench to bedside. J Hematol Oncol. 2013 Apr 12;6:27. PMID: 23587417.
Glucocorticoid
1,8-Diaza-anthracene-tetrone; JNK and ERK5 inhi...
Diterpene found in Anisomeles.
Triterpene sapogenin found in species of Panax;...
Aminoquinoline, binds heme, causes cell lysis.<...
Abl inhibitor.
SV2A synaptic vesicle inhibitor.
GABA-A α5/3/2 positive modulator.
mTOR inhibitor.
Derivative of methyl caffeate, hydroxycinnamic ...
Endogenous peptide hormone, involved in stress ...
Acyl-CoA synthetase inhibitor.
Benzazepine derivative; D1 partial agonist, pot...
Degrades of BET proteins.
TRPC5, NS4B, histamine H1 inhibitor.
Monoterpene coumarin ether found in Citrus; PPA...
Macrolide lactone antibiotic.
Sesquiterpene found in Curcuma.
Synthesis impurity